Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: German affirmation + Counterpart statement = over a month later, nothing

RE: 1Rare1, "Based on the fact that PTSC is making a concerted effort to push the MMP to the background, I'm starting to wonder what a recert."

That’s exactly what I have been thinking. Our hopes probably should be on the new businesses. But those are longer term propositions – maybe a year before we are likely to see $7 million revenue which equates to $.01 EPS. When might we hit $21 million (3 cents EPS) from these new businesses? I’d guess 2012 +

Share
New Message
Please login to post a reply